SCHEMBL9865463

SCHEMBL9865463

CC(SCCN)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 4/20 0.67
SLC6A3 Q01959 4/20 0.67
CYP1A2 P05177 2/20 0.67
CYP2D6 P10635 2/20 0.67
CYP2C19 P33261 2/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2C9 P11712 1/20 0.67
TSHR P16473 1/20 0.67
TAAR1 Q96RJ0 4/20 0.52
HRH1 P35367 2/20 0.46
KIF11 P52732 2/20 0.46
HTR2A P28223 2/20 0.44
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
AOC3 Q16853 2/20 0.41
SLC6A2 P23975 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13934689 0.81 TRPA1 (0.44) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL7439094 0.80 SLC6A3 (1.00) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL7438013 0.78 SLC6A3 (0.96) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL21647216 0.78 CYP1A2 (0.41) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL12128404 0.77 KMT2A (0.44) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL31290434 0.76 CYSLTR2 (0.50) CYP2C19
SCHEMBL9771151 0.76 SLC6A3 (0.81) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL31290368 0.76 HTR2A (0.42) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL11777659 0.76 TSHR (0.40) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19
SCHEMBL18594722 0.76 KMT2A (0.43) SLC6A4SLC6A3CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed